This webinar is essential for researchers interested in the use of continuous EEG telemetry for seizure assessment in rodent epilepsy models.

Synchronization is essential for information processing in neural networks. However, prolonged neuronal hyper-synchronization—seizure activity—can result in permanent brain damage. To help study the disease, chemoconvulsants such as pilocarpine and soman can be used to induce epilepsy in rodents. Telemetry is a particularly effective tool for this research, as it allows the detection of hyper-synchronizations and continuous data collection for physiological and pharmacological studies.

In this webinar sponsored by Data Sciences International, Dr. Marcio Furtado presents research highlighting the importance of anomalous EEG detection to study experimental epilepsy and assess the efficacy of potential anticonvulsants and neuroprotectants. He also discusses why continuous EEG monitoring at a high sampling rate is critical to properly detect seizures and how to effectively deal with large telemetry data sets.

Click to watch the webinar recording. To view the presentation full screen simply click the square icon located in the bottom-right corner of the video-viewer.

Resources

To download a PDF copy of the presentation, click on the “LinkedIn SlideShare” icon located in the bottom-right corner of the slide-viewer. From the SlideShare landing page click the “Download” button to retrieve the file.

Presenters

CEO
BioSEaD

Production Partner

Data Sciences International

Data Sciences International (DSI) is the leader in preclinical physiological monitoring offering telemetry, instrumentation, software and services to help advance science. Industries served include: Pharmaceuticals, Academia, Contract Research Organizations, Biological and Chemical Defense, Medical Devices, Government, and Biotechnology.

Harvard Bioscience, Inc.

Harvard Bioscience is a global leader in the manufacturing and distribution of solutions to advance life science research. For over 110 years, we have served the changing needs of life scientists in over 100 countries. Our expanding portfolio of brands include instruments for organ and animal research, cell analysis, molecular biology, fluidics, and laboratory consumables.

Additional Content From Data Sciences International

Additional Content From Harvard Bioscience, Inc.

Related Content